Is a specific drinking pattern a consistent feature of the Mediterranean diet in Spain in the XXI century?

Background And Aim: Over the last 50 years, people in Spain have increasingly been eating their main meal away from home and are shifting from the typical Mediterranean diet (MD). In addition, wine consumption has decreased whereas beer intake has risen. Consequently, it is uncertain if the Mediterranean drinking pattern (MDP; moderate alcohol intake mainly from wine and during meals) is a habitual feature of the MD today.

Three-year changes in drinking patterns in Spain: a prospective population-based cohort study.

Background: This study examined changes in alcohol drinking patterns (DP) and associated variables in a Mediterranean country.

Methods: Changes in DP between baseline (2008-2010) and follow-up (2012-2013) were examined on a Spanish population-based cohort of 2254 adults (18-59 years) using multinomial logistic regression. Heavy consumption was defined as ≥40 g/day of alcohol in men (≥24 g/day in women) and binge drinking (BD) as the intake of ≥80 g of alcohol in men (≥60 g in women) on one occasion in the previous month.

Alcohol drinking patterns and health-related quality of life reported in the Spanish adult population.

Objectives: To examine the association between alcohol drinking patterns and health-related quality of life (HRQL).

Methods: Population-based cross-sectional study was conducted in 2008-2010 among 12,715 adult individuals in Spain. HRQL was assessed with the SF-12 questionnaire and alcohol intake with a diet history.

How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?

Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease (COPD). Since inflammatory processes play a key role in the pathogenesis of the disease and ICSs have been shown to be very effective in controlling asthma, their use in COPD patients has become widespread. However, their efficacy in COPD is more limited than in asthma, since the type of inflammation in COPD is predominantly neutrophilic and resistant to corticosteroids.